Allogeneic haematopoietic stem-cell transplantation (HSCT) is frequently applied as part of
the treatment in patients with acute myeloid leukaemia (AML) in their first or subsequent …

Allogeneic hematopoietic stem cell transplantation (HSCT) is the recommended therapy for
patients with relapsed acute myelogenous leukemia (AML), despite little evidence showing …

Purpose Patients with acute myeloid leukemia (AML) who are in morphologic complete
remission are typically considered separately from patients with active disease (ie,≥ 5 …

Postremission therapy in patients with acute myeloid leukemia (AML) may consist of
continuing chemotherapy or transplantation using either autologous or allogeneic stem …

Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy generally
associated with poor prognosis. Allogeneic hematopoietic cell transplantation (alloHCT) …

Background The optimum post-remission treatment (PRT) in acute myeloid leukaemia (AML)
is still a matter of debate. Consolidation treatments include chemotherapy with high-dose …

Acute myeloid leukaemia (AML) is the commonest indication for allogeneic stem cell
transplantation (allo‐SCT) worldwide. The accumulated experience of allografting in AML …

To assess the place of allogeneic hematopoietic stem cell transplantation (HSCT) in the
advanced stage of acute myeloid leukemia (AML), we retrospectively analyzed 379 …

BACKGROUND The efficacy of allogeneic hematopoietic stem cell transplantation (allo‐
HSCT) from a human leukocyte antigen‐identical sibling donor remains controversial for …

Progress in the last decade has improved the understanding of leukemia biology. Molecular
markers in combinations with cytogenetics have improved the risk stratification of acute …